Effect of Fluid Regimen on Acute Kidney Injury
Effects of Peroperative Liberal and Restrictive Fluid Regimens on Protection From Postoperative Acute Kidney Injury in Patients Undergoing Partial or Radical Nephrectomy; Randomized Controlled Trial
1 other identifier
interventional
80
1 country
1
Brief Summary
Postoperative acute kidney injury (AKI) is an important surgical complication that increases hospital stay and mortality when it occurs after kidney surgery. Studies investigating the effects of restrictive or liberal fluid regimen on postoperative AKI during radical/partial nephrectomy have given controversial results. It is important to recognize AKI early so that supportive treatments can be started early. Serum creatinine level, which is frequently used in the detection of AKI, increases late and causes a delay in diagnosis. It has been reported that cystatin C level increases earlier than creatinine in the diagnosis of AKI, so it can be used for early diagnosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 26, 2023
CompletedFirst Posted
Study publicly available on registry
February 13, 2024
CompletedStudy Start
First participant enrolled
May 29, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 20, 2024
CompletedNovember 26, 2024
November 1, 2024
17 days
December 26, 2023
November 25, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
rate of acute renal failure
To determine whether the restrictive or liberal fluid regimen applied during partial or radical nephrectomy surgery causes acute renal failure in the early postoperative period.
48 hour
Secondary Outcomes (1)
Creatinine
48 hour
Study Arms (2)
R- fluid group
EXPERIMENTALThe group to which restrictive fluid replacement will be applied (Group R); 3 ml/kg/hour Ringer lactate (RL) solution will be given.
L- fluid group
EXPERIMENTAL7 ml/kg/hour RL solution will be given to the group that will receive a liberal liquid regimen (Group L).
Interventions
3 mL/kg/hour Ringer Lactate will be given peroperatively to the restrictive group (Group R).
7 ml/kg/hour Ringer Lactate will be given peroperatively to the liberal group (Group L).
Eligibility Criteria
You may qualify if:
- American Society of Anesthesiologists (ASA) I-II-III,
- The opposite kidney is in normal function
You may not qualify if:
- Those who are planned for bilateral partial nephrectomy,
- Patients with preoperative chronic kidney disease,
- Those using preoperative medications known to cause renal toxicity such as aminoglycosides, aspirin and angiotensin converting enzyme inhibitors,
- Coronary artery disease
- Congestive heart failure
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mugla Sitki Kocman Training and Research Hospital
Muğla, 48000, Turkey (Türkiye)
Related Publications (1)
Yasar E, Toker MK, Saruhan E, Gursoy C. Impact of liberal versus restrictive fluid management on acute kidney injury after nephrectomy: a randomised controlled trial with cystatin C evaluation. BMC Urol. 2025 Oct 27;25(1):270. doi: 10.1186/s12894-025-01954-w.
PMID: 41146149DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Eylem Yasar, M.D
Mugla Sitki Kocman Training and Research Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Patients and those evaluating blood samples will not know which group they are in the study.
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 26, 2023
First Posted
February 13, 2024
Study Start
May 29, 2024
Primary Completion
June 15, 2024
Study Completion
June 20, 2024
Last Updated
November 26, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share
All data, except patient names, will be shared with the editor upon request after the article is accepted.